A Key Risk Indicator Approach to Central Statistical Monitoring in Multicentre Clinical Trials: Method Development in the Context of an Ongoing Large-Scale Randomized Trial

Trials - United Kingdom
doi 10.1186/1745-6215-12-s1-a135
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Performance of a Statistical Model to Predict Stroke Outcome in the Context of a Large, Simple, Randomized, Controlled Trial of Feeding

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2002English

Ongoing Clinical Trials

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2016English

Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Statistical Inference of Covariate-Adaptive Randomized Clinical Trials

English

Development and Impact of an Intervention to Boost Recruitment in a Multicenter Pediatric Randomized Clinical Trial

Clinical Pediatrics
Child HealthPediatricsPerinatology
2013English

Effect Sizes in Ongoing Randomized Controlled Critical Care Trials

Critical Care
Critical CareIntensive Care Medicine
2017English

Parallel Multicentre Randomised Trial of a Clinical Trial Question Prompt List in Patients Considering Participation in Phase 3 Cancer Treatment Trials

BMJ Open
Medicine
2017English

Significance Level and the Number of Trials in Confirmatory Clinical Trials in Relation to “Statistical Principles for Clinical Trials”

Japanese Journal of Biometrics
2003English

Post-Trial Follow-Up Methodology in Large Randomized Controlled Trials: A Systematic Review Protocol

Systematic Reviews
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy